Kimberly Fisher to Middle Aged
This is a "connection" page, showing publications Kimberly Fisher has written about Middle Aged.
Connection Strength
0.603
-
D'Addario AE, Fukunaga MI, King AM, Singh S, Mazor KM, Fisher KA. Lung cancer screening: What do physicians say to reluctant patients and what do patients want them to say? Patient Educ Couns. 2025 May; 134:108698.
Score: 0.075
-
Fisher KA, Epstein MM, Nguyen N, Fouayzi H, Crawford S, Linas BP, Mazor KM. COVID-19 clinical trials: who is likely to participate and why? J Comp Eff Res. 2024 08; 13(8):e230181.
Score: 0.072
-
Fisher KA, Singh S, Stone RT, Nguyen N, Crawford S, Mazor KM. Primary care providers' views of discussing COVID-19 vaccination with vaccine hesitant patients: A qualitative study. Patient Educ Couns. 2024 Oct; 127:108369.
Score: 0.072
-
Fisher KA, Mazor KM, Epstein MM, Goldthwait L, Abu Ghazaleh H, Zhou Y, Crawford S, Marathe J, Linas BP. Long COVID awareness and receipt of medical care: a survey among populations at risk for disparities. Front Public Health. 2024; 12:1360341.
Score: 0.071
-
Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. 2020 12 15; 173(12):964-973.
Score: 0.055
-
Fisher KA, Gallagher TH, Smith KM, Zhou Y, Crawford S, Amroze A, Mazor KM. Communicating with patients about breakdowns in care: a national randomised vignette-based survey. BMJ Qual Saf. 2020 04; 29(4):313-319.
Score: 0.052
-
Fisher KA, Smith KM, Gallagher TH, Huang JC, Borton JC, Mazor KM. We want to know: patient comfort speaking up about breakdowns in care and patient experience. BMJ Qual Saf. 2019 03; 28(3):190-197.
Score: 0.048
-
Fisher K, Smith K, Gallagher T, Burns L, Morales C, Mazor K. We Want to Know: Eliciting Hospitalized Patients' Perspectives on Breakdowns in Care. J Hosp Med. 2017 08; 12(8):603-609.
Score: 0.044
-
Fisher KA, Ahmad S, Jackson M, Mazor KM. Surrogate decision makers' perspectives on preventable breakdowns in care among critically ill patients: A qualitative study. Patient Educ Couns. 2016 10; 99(10):1685-93.
Score: 0.040
-
Fisher KA, Serlin DM, Wilson KC, Walter RE, Berman JS, Farber HW. Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment. Chest. 2006 Nov; 130(5):1481-8.
Score: 0.021
-
Tai-Seale M, Cheung M, Vaida F, Ruo B, Walker A, Rosen RL, Hogarth M, Fisher KA, Singh S, Yood RA, Garber L, Saphirak C, Li M, Chan AS, Yu EE, Kallenberg G, Longhurst CA, Millen M, Stults CD, Mazor KM. Patient-Clinician Communication Interventions Across Multiple Primary Care Sites: A Cluster Randomized Clinical Trial. JAMA Health Forum. 2024 Dec 06; 5(12):e244436.
Score: 0.018
-
Epstein MM, Saphirak C, Zhou Y, LeBlanc C, Rosmarin AG, Ash A, Singh S, Fisher K, Birmann BM, Gurwitz JH. Identifying monoclonal gammopathy of undetermined significance in electronic health data. Pharmacoepidemiol Drug Saf. 2020 01; 29(1):69-76.
Score: 0.013
-
Lindenauer PK, Shieh MS, Stefan MS, Fisher KA, Haessler SD, Pekow PS, Rothberg MB, Krishnan JA, Walkey AJ. Hospital Procalcitonin Testing and Antibiotic Treatment of Patients Admitted for Chronic Obstructive Pulmonary Disease Exacerbation. Ann Am Thorac Soc. 2017 Dec; 14(12):1779-1785.
Score: 0.011
-
Stefan MS, Pekow PS, Shieh MS, Hill NS, Rothberg MB, Fisher KA, Lindenauer PK. Hospital Volume and Outcomes of Noninvasive Ventilation in Patients Hospitalized With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Crit Care Med. 2017 Jan; 45(1):20-27.
Score: 0.011